2009
Asset Medical was founded in Istanbul.
COMPANY
History
2011
Started to export FlowArt® Sterile Infusion Therapy Devices to Italy.
2010
Started to manufacture the FlowArt® Sterile Infusion Therapy Devices, its first patented needle-free valve.
2016
Acquired by the Netherlands-based “General Medical Devices” and attracted significant capital investment from private equity fund Pera Capital Partners.
2012
Received the “Woman Entrepreneur of the Year” award from the Turkish Ministry of Science, Industry, and Technology.
2013
Manufactured and launched the first “One Directional Needle-Free Valve”.
2018
FlowArt® Sterile Infusion Therapy Devices received approval and certification from the Australian Department of Health (TGA).
2020
FlowArt® and NeutrArt® Needle free Connectors and manifolds received approval and 510(K) certification by USA Food and Drug Authority (FDA).
2019
global launch of the “SwabArt® Disinfecting Caps.” FlowArt® Sterile Infusion Therapy Devices received approval and certification from Brazilian Health Regulatory Agency (ANVISA).
2022
Based on increasing International demand, Asset Medical quadrupled production capabilities.
2021
Rapids International expansion and Global launch of the Neutral Displacement NeutrArt® Needle-Free Connector.
2009
Asset Medical was founded in Istanbul.
2010
Started to manufacture the FlowArt® Sterile Infusion Therapy Devices, its first patented needle-free valve.
2011
Started to export FlowArt® Sterile Infusion Therapy Devices to Italy.
2012
Received the “Woman Entrepreneur of the Year” award from the Turkish Ministry of Science, Industry, and Technology.
2013
Manufactured and launched the first “One Directional Needle-Free Valve”.
2016
Acquired by the Netherlands-based “General Medical Devices” and attracted significant capital investment from private equity fund Pera Capital Partners.
2018
FlowArt® Sterile Infusion Therapy Devices received approval and certification from the Australian Department of Health (TGA).
2019
Global launch of the “SwabArt® Disinfecting Caps.” FlowArt® Sterile Infusion Therapy Devices received approval and certification from Brazilian Health Regulatory Agency (ANVISA).
2020
FlowArt® and NeutrArt® Needle Free Connectors and manifolds received approval and 510(K) certification by USA Food and Drug Authority (FDA).
2021
Rapids International expansion and Global launch of the Neutral Displacement NeutrArt® Needle-Free Connector.
2022
Based on increasing International demand, Asset Medical quadrupled production capabilities.
